The influence of microbial physiology on biocatalyst activity and efficiency in the terminal hydroxylation of n-octane using Escherichia coli expressing the alkane hydroxylase, CYP153A6

Microbial Cell Factories

Volumn 12, Issue 1, 2013, Pages

  Olaofe, Oluwafemi A ^a   Fenner, Caryn J ^a   Gudiminchi, Rama Krishna ^a,b   Smit, Martha S ^a,b   Harrison, Susan T L ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

1 Octanol; Alkane hydroxylation; CYP153A6; Octane; Whole cell biocatalysis

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 153A6; FERREDOXIN; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; GLUCOSE; OCTANE; OCTANOL; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERIUM CULTURE; BIOCATALYSIS; BIOCATALYST; BIOPROCESS; BIOTRANSFORMATION; CELL LEVEL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ESCHERICHIA COLI; FED BATCH CULTURE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIGH TEMPERATURE; HYDROXYLATION; MOLECULAR INTERACTION; NONHUMAN; OPERON; PROCESS OPTIMIZATION; PRODUCTIVITY; PROTEIN EXPRESSION;

ALKANE 1-MONOOXYGENASE; BATCH CELL CULTURE TECHNIQUES; BIOCATALYSIS; BIOREACTORS; ESCHERICHIA COLI; GLUCOSE; HYDROXYLATION; OCTANES; RECOMBINANT PROTEINS; TEMPERATURE;

ESCHERICHIA COLI;

EID: 84872765695     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-12-8     Document Type: Article

References (37)

1. Ayala M, Torres E. Enzymatic activation of alkanes: constraints and prospective. Applied Catalysis A: General 2004, 272:1-13.
2. Buhler B, Schmid A. Process implementation aspects for biocatalytic hydrocarbon oxyfunctionalization. J Biotechnol 2004, 113:183-210. 10.1016/j.jbiotec.2004.03.027, 15380656.
3. Farinas ET, Schwaneberg U, Glieder A, Arnold FH. Directed evolution of a cytochrome P450 monooxygenase for alkane oxidation. Adv Synth Catal 2001, 343(6-7):601-606.
4. Bordeaux M, Galarneau A, Fajula F, Drone J. A regioselective biocatalyst for alkane activation under mild conditions. Angew Chem Int Ed Engl 2011, 123:2123-2127.
5. Fujii T, Narikawa T, Sumisa F, Arisawa A, Takeda K, Kato J. Production of α,ω-alkanediols using Escherichia coli expressing a cytochrome P450 from Acinetobacter sp. OC4. Biosci Biotechnol Biochem 2006, 70((6):1379-1385.
6. Funhoff EG, Bauer U, Garcia-Rubio I, Witholt B, van Beilen JB. CYP153A6, a soluble P450 oxygenase catalyzing terminal-alkane hydroxylation. J Bacteriol 2006, 188(14):5220-5227. 10.1128/JB.00286-06, 1539980, 16816194.
7. Koch DJ, Chen MM, van Beilen JB, Arnold FH. In vivo evolution of butane oxidation by terminal alkane hydroxylases AlkB and CYP153A6. Appl Environ Microbiol 2009, 75(2):337-344. 10.1128/AEM.01758-08, 2620723, 19011057.
8. Nodate M, Kubota M, Misawa N. Functional expression system for CYP450 genes using the reductase domain of self-sufficient P450RhF from Rhodococcus sp. NCIMB 9784. Appl Microbiol Biotechnol 2006, 71:455-462. 10.1007/s00253-005-0147-y, 16195793.
9. Chang MCY, Eachus RA, Trieu W, Ro DK, Keasling JD. Engineering Escherichia coli for production of functionalized terpenoids using plant p450s. Nat Chem Biol 2007, 3:274-277. 10.1038/nchembio875, 17438551.
10. Fasan R, Chen MM, Crook NC, Arnold FH. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting native like catalytic properties. Angew Chem Int Ed 2007, 46:8414-8418.
11. Glieder A, Farinas ET, Arnold FH. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nat Biotechnol 2002, 20:1135-1139. 10.1038/nbt744, 12368811.
12. Julsing MK, Cornelissen S, Buhler B, Schmid A. Heme-iron oxygenases: powerful industrial biocatalysts?. Curr Opin Chem Biol 2008, 12:177-186. 10.1016/j.cbpa.2008.01.029, 18258209.
13. Liu SC, Li C, Fang XC, Cao ZA. Optimal pH control strategy for high level production of long-chain α, ω - dicarboxylic acid by Candida tropicalis. Enzyme Microb Technol 2004, 34:73-77.
14. Pflug S, Richter SM, Urlacher VB. Development of a fed-batch process for the production of cytochrome P450 monooxygenase CYP102A1 from Bacillus megaterium in E. coli. J Biotechnol 2007, 129:481-488. 10.1016/j.jbiotec.2007.01.013, 17346843.
15. Pritchard MP, Osseitian R, Li DN, Henderson CJ, Burchell B. A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1. Arch Biochem Biophys 1997, 345:342-354. 10.1006/abbi.1997.0265, 9308909.
16. Baik SH. Biotransformation of medium-chain alkanes using recombinant P450 monooxygenase from Alcanivorax borkumensis SK2 expressed in Escherichia coli. Korean J Chem Eng 2010, 27(3):905.
17. Fujita N, Sumisa F, Shindo K, Kabumoto H, Arisawa A, Ikenaga H, Misawa N. Comparison of two vectors for functional expression of a bacterial cytochrome P450 gene in Escherichia coli using CYP153 genes. Biosci Biotechnol Biochem 2009, 73:1825-1830. 10.1271/bbb.90199, 19661686.
18. Kubota M, Nodate M, Yasumoto-Hirose M, Uchiyama T, Kagami O, Shizuri Y, Misawa N. Isolation and functional analysis of cytochrome P450 CYP153A genes from various environments. Biosci Biotechnol Biochem 2005, 69(12):2421-2430. 10.1271/bbb.69.2421, 16377903.
19. Gudiminchi RK, Randall C, Opperman DJ, Olaofe OA, Harrison STL, Albertyn J, Smit MS. Whole-cell hydroxylation of n-octane by Escherichia coli strains expressing the CYP153A6 operon. Appl Microbiol Biotechnol 2012, 96(6):1507-1516. 10.1007/s00253-012-3984-5, 22410745.
20. Cornelissen S, Liu S, Deshmukh AT, Schmid A, Buhler B. Cell physiology rather than enzyme kinetics can determine the efficiency of cytochrome P450-catalysed C-H-oxyfunctionalization. J Ind Microbiol Biotechnol 2011, 38:1359-1370. 10.1007/s10295-010-0919-y, 21559976.
21. Meyer D, Buhler B, Schmid A. Process and catalyst design objectives for specific redox biocatalysis. Adv Appl Microbiol 2006, 59:53-91.
22. Siedler S, Bringer S, Bott M. Increased NADPH availability in Escherichia coli: improvement of the product per glucose ration in reductive whole-cell biotransformation. Appl Microbiol Biotechnol 2011, 92:929-937. 10.1007/s00253-011-3374-4, 21670981.
23. Krause M, Ukkonen K, Haataja T, Ruottinen M, Glumoff T, Neubauer A, Neubauer P, Vasala A. A novel fed-batch based cultivation method provides high cell-density and improves yield of soluble recombinant proteins in shaken cultures. Microb Cell Fact 2010, 9(11):1-11. 2818619, 20067629.
24. Choi JH, Keum KC, Lee SY. Production of recombinant proteins by high cell density culture of Escherichia coli. Chem Eng Sci 2006, 61:876-885.
25. Olaofe OA, Burton SG, Cowan D, Harrison STL. Improving the production of a thermostable amidase through optimising IPTG induction in a highly dense culture of recombinant Escherichia coli. Biochem Eng J 2010, 52:19-24.
26. Staijen IE, van Beilen JB, Witholt B. Expression, stability and performance of the three-component alkane mono-oxygenase of Pseudomonas oleovorans in Escherichia coli. Eur J Biochem 2000, 1957:1965.
27. Axe DD, Bailey JE. Transport of lactate and acetate through the energized cytoplasmic membrane of Escherichia coli. Biotechnol Bioeng 1995, 47:8-19. 10.1002/bit.260470103, 18623362.
28. Warnecke T, Gill RT. Organic acid toxicity, tolerance, and production in Escherichia coli biorefining applications. Microb Cell Fact 2005, 4:25. 10.1186/1475-2859-4-25, 1208944, 16122392.
29. de Bont JAM. Solvent-tolerant bacteria in biocatalysis. Trends Biotechnol 1998, 16:493-499.
30. Julsing MK, Kuhn D, Schmid A, Buhler B. Resting cells of recombinant E. coli show high epoxidation yields on energy source and high sensitivity to product inhibition. Biotechnol Bioeng 2012, 109((5):1109-1119.
31. Favre-Bulle O, Witholt B. Biooxidation of n-octane by a recombinant Escherichia coli in a two-liquid-phase system: Effect of medium components on cell growth and alkane oxidation activity. Enzyme Microb Tech 1992, 14:931-937.
32. Brown MRW, Collier PJ, Gilbert P. Influence of growth rate on susceptibility to antimicrobial agents: Modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother 1990, 34(9):1623-1628. 10.1128/AAC.34.9.1623, 171894, 2285273.
33. Julsing MK, Schrewe M, Cornelissen S, Hermann I, Schmid A, Buhler B. Outer membrane protein AlkL boosts biocatalytic oxyfunctionalization of hydrophobic substrates in Escherichia coli. Appl Environ Microbiol 2012, 78(16):5724-5733. 10.1128/AEM.00949-12, 3406146, 22685130.
34. Grant C, Woodley JM, Baganz F. Whole-cell bio-oxidation of n-dodecane using the alkane hydroxylase system of P. putida GPo1 expressed in E. coli. Enzyme Microb Technol 2011, 48:480-486. 10.1016/j.enzmictec.2011.01.008, 22113020.
35. Blank LM, Ebert BE, Buhler B, Schmid A. Metabolic capacity estimation of Escherichia coli as platform for redox biocatalysis: Constraint based modeling and experimental verification. Biotechnol Bioeng 2008, 100(6):1050-1065. 10.1002/bit.21837, 18553399.
36. Mathys RG, Kut OM, Witholt B. Alkanol removal from the apolar phase of a two-liquid phase bioconversion system. Part 1: Comparison of a less volatile and a more volatile in-situ extraction solvent for the separation of 1-octanol by distillation. J Chem Technol Biotechnol 1998, 71:315-325.
37. Guengerich FP, Martin MV, Sohl CD, Cheng Q. Measurement of cytochrome P450 and NADPH-cytochrome P450 reductase. Nat Protoc 2009, 4(9):1245-1251. 10.1038/nprot.2009.121, 19661994.